Large PharmaUSLLYAggressive Acquisition Appetite
Eli Lilly Deal History & Licensing Activity
Eli Lilly is a large pharma headquartered in US. Over the past three years, Eli Lilly has been involved in 69 licensing and acquisition transactions, with a primary focus on Small Molecules (19 deals). The company currently has 50 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
20
Active Trials
50
Top Modality
Small Molecules
Focus Area
Solid Tumors
Eli Lilly Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Eli Lilly in the past 12 months.
| Asset |
|---|